Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ImmuCell Corporation (ICCC) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ImmuCell Corporation (ICCC), most recent 12 months reported: revenue $30.68M, net income $787.37K, free cash flow $4.21M. Latest balance sheet on file: liquid cash $8.86M, total debt $8.3M, net cash $557.32K. From SEC filings. Others in In Vitro & In Vivo Diagnostic Substances: Neogen Corporation · MYRIAD GENETICS, INC. · INTELLIA THERAPEUTICS, INC. · Alpha Teknova, Inc. · Anbio Biotechnology · Aspira Women’s Health Inc. · BIOMERICA, INC. · VolitionRx Limited

Stock screener

Watchlist